Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis | The BMJ
Network pharmacology approach to decipher signaling pathways associated with target proteins of NSAIDs against COVID-19 | Scientific Reports
Non-steroidal anti-inflammatory drugs in the era of the Covid-19 pandemic in the context of the human and the environment - ScienceDirect
Dentistry Journal | Free Full-Text | Loxoprofen Sodium Versus Diclofenac Potassium for Post-Dental Extraction Pain Relief: A Randomized, Triple-Blind, Clinical Trial
Diclofenac: Package Insert - Drugs.com
The use of non-steroidal anti-inflammatory drugs (NSAIDs) in patients with COVID-19
Safe use of paracetamol and high-dose NSAID analgesia in dentistry during the COVID-19 pandemic | British Dental Journal
Voltaren | Diclofenac
Celecoxib versus omeprazole and diclofenac in patients with osteoarthritis and rheumatoid arthritis (CONDOR): a randomised trial - The Lancet
Medicina | Free Full-Text | Is Antioxidant Therapy a Useful Complementary Measure for Covid-19 Treatment? An Algorithm for Its Application
Frontiers | Drugs for the prevention and treatment of COVID-19 and its complications: An update on what we learned in the past 2 years
BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin
BioMed | Free Full-Text | Early Multi-Target Treatment of Mild-to-Moderate COVID-19, Particularly in Terms of Non-Steroidal Anti-Inflammatory Drugs and Indomethacin
Early use of non-steroidal anti-inflammatory drugs in COVID-19 might reverse pathogenesis, prevent complications and improve clinical outcomes - ScienceDirect
Some COX inhibitors/NSAIDs increase COVID-19 severity
Frontiers | Efficacy and safety profile of corticosteroids and non-steroidal anti-inflammatory drugs in COVID-19 management: A narrative review
Home as the new frontier for the treatment of COVID-19: the case for anti-inflammatory agents - The Lancet Infectious Diseases
Sensible to avoid ibuprofen for coronavirus, says top adviser - Pulse Today
Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study - The Lancet Rheumatology
Frontiers | Effect of the chronic medication use on outcome measures of hospitalized COVID-19 patients: Evidence from big data
Hancock trial evaluating manipulation + diclofenac for acute low back pain is a PEDro Top 20 Trial - YouTube
Are prescribers not aware of cardiovascular contraindications for diclofenac? A claims data analysis - Scholle - 2020 - Journal of Internal Medicine - Wiley Online Library
Ibuprofen, other NSAIDs not tied to worse COVID illness, death | CIDRAP